行业回暖!盘点2025年CXO订单最高的10家公司:药明系领跑,凯莱英、泰格医药等巨头订单激增

摩熵医药
6 hours ago

2025年,全球CXO行业在逐步回暖,市场需求结构性分化愈发明显。一方面,跨国药企持续加码对ADC、多肽、寡核苷酸等新分子类型的投入;另一方面,国内创新药企在融资环境改善与出海加速的双重驱动下,研发活跃度显著回升。数据显示,2025年全球CXO市场规模预计将达到1966亿美元,2021至2025年复合年增长率(CAGR)为14.0%。与此同时,中国市场正以更快的速度扩容——2025年CXO市场规模...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10